Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

EASE Trial: Exhale Airway Stents for Emphysema

Study:

A Randomized, Double-blind Study to Evaluate the Safety and Effectiveness of the Exhale® Drug-Eluting Stent in Homogeneous Emphysema Subjects With Severe Hyperinflation

Rationale:

n/a

Purpose:

This is an international clinical research study evaluating the safety and effectiveness of a new procedure called airway bypass. The goal of this research is to see if airway bypass can relieve hyperinflation (overfilling) of the lungs, thereby improving lung function and reducing shortness of breath in patients with severe homogeneous (diffuse) emphysema. "EASE" stands for Exhale Airway Stents for Emphysema.

Study Status: Active, not recruiting

Recruiting:
n/a

Condition Intervention Phase
Emphysema Device: Exhale® Drug-Eluting Stent
Device: Sham control
Phase 3

Verified by Broncus Technologies January, 2011

Sponsored by: Broncus Technologies
Information provided by: Broncus Technologies
ClinicalTrials.gov identifier: NCT00391612

Study Type: Interventional

Study Design: Allocation: Randomized, Control: Placebo Control, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Outcomes Assessor), Primary Purpose: Treatment

Cleveland Clinic Foundation
Cleveland, Ohio 44195
United States

Joel D. Cooper, MD, FACS, FRCS., Principal Investigator
Gerhard W. Sybrecht, Prof. Dr. med.., Principal Investigator

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site